Literature DB >> 27012300

Impaired Cerebrovascular Reactivity Predicts Recurrent Symptoms in Patients with Carotid Artery Occlusion: A Hypercapnia BOLD fMRI Study.

S D Goode1, N Altaf2, S Munshi3, S T R MacSweeney4, D P Auer5.   

Abstract

BACKGROUND AND
PURPOSE: A key factor in predicting recurrent ischemic episodes in patients with carotid artery occlusion is the presence of hemodynamic impairment. There is, however, no consensus on how to best assess this risk in terms of imaging modalities or thresholds used. Here we investigated whether a predefined threshold of hemispheric asymmetry in hypercapnia fMRI predicts recurrent symptoms in patients with carotid artery occlusion.
MATERIALS AND METHODS: We studied 23 patients (2 women) with a mean age of 67.5 ± 9 years. Patients were assessed for recurrent ischemic events until lost to follow-up, study end, death, or recurrent ischemic event. Hypercapnia fMRI was used to assess the cerebrovascular reserve and quantify the percentage signal change in GM in the MCA territory and the hemispheric asymmetry index. Kaplan-Meier survival analysis and log-rank tests were performed to assess differences between patients with normal or abnormal hemispheric indices.
RESULTS: The median follow-up was 20 months. During this period, 8 patients experienced recurrent events, and 15 did not. The percentage signal change in GM in the MCA territory was significantly decreased in those patients with recurrent events compared with those without (2.39 ± 0.22 versus 2.70 ± 0.42, P = .032). The normal hemispheric index predicted event-free survival during follow-up (median, 20 months) for both the combined outcome (recurrent events and/or death, log-rank, P = .034) and recurrent retinal or ipsilateral ischemic events only (log-rank, P = .012).
CONCLUSIONS: The hemispheric asymmetry index derived from hypercapnia fMRI showed hemodynamic impairment in more than half of the studied patients with carotid occlusion, and those patients showed a higher risk of recurrent ischemic symptoms.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 27012300      PMCID: PMC7960300          DOI: 10.3174/ajnr.A4739

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  37 in total

1.  General multilevel linear modeling for group analysis in FMRI.

Authors:  Christian F Beckmann; Mark Jenkinson; Stephen M Smith
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

2.  Multilevel linear modelling for FMRI group analysis using Bayesian inference.

Authors:  Mark W Woolrich; Timothy E J Behrens; Christian F Beckmann; Mark Jenkinson; Stephen M Smith
Journal:  Neuroimage       Date:  2004-04       Impact factor: 6.556

3.  Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases.

Authors:  H Yamauchi; H Fukuyama; Y Nagahama; H Nabatame; M Ueno; S Nishizawa; J Konishi; H Shio
Journal:  J Nucl Med       Date:  1999-12       Impact factor: 10.057

4.  Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.

Authors:  Makoto Isozaki; Yoshikazu Arai; Takashi Kudo; Yasushi Kiyono; Masato Kobayashi; Toshihiko Kubota; Ken-ichiro Kikuta; Hidehiko Okazawa
Journal:  Ann Nucl Med       Date:  2010-03-18       Impact factor: 2.668

Review 5.  Cerebral hemodynamics in ischemic cerebrovascular disease.

Authors:  W J Powers
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

6.  Effect of acetazolamide reactivity on [corrected] long-term outcome in patients with major cerebral artery occlusive diseases.

Authors:  C Yokota; Y Hasegawa; K Minematsu; T Yamaguchi
Journal:  Stroke       Date:  1998-03       Impact factor: 7.914

7.  Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study.

Authors:  Kuniaki Ogasawara; Akira Ogawa; Takashi Yoshimoto
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

8.  Cerebral haemodynamic changes after extracranial-intracranial bypass surgery.

Authors:  J M Gibbs; R J Wise; D J Thomas; A O Mansfield; R W Russell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

9.  Course of cerebrovascular reactivity in patients with carotid artery occlusions.

Authors:  B Widder; B Kleiser; H Krapf
Journal:  Stroke       Date:  1994-10       Impact factor: 7.914

10.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

Authors:  R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers
Journal:  JAMA       Date:  1998 Sep 23-30       Impact factor: 56.272

View more
  5 in total

Review 1.  Neuroimaging of vascular reserve in patients with cerebrovascular diseases.

Authors:  Meher R Juttukonda; Manus J Donahue
Journal:  Neuroimage       Date:  2017-10-12       Impact factor: 6.556

2.  Effects of sevoflurane versus propofol on cerebrovascular reactivity to carbon dioxide during laparoscopic surgery.

Authors:  Chunyi Wang; Cheng Ni; Gang Li; Yan Li; Liyuan Tao; Nan Li; Jun Wang; Xiangyang Guo
Journal:  Ther Clin Risk Manag       Date:  2017-10-10       Impact factor: 2.423

3.  Cerebrovascular Reactivity and Carotid Intima-Media Thickness in Opium Dependents: A Case-Control Study.

Authors:  Akbar Hamziee-Moghadam; Farhad Iranmanesh; Ali Arabpour-Fathabadi; Forugh Mohammadi
Journal:  Addict Health       Date:  2018-04

4.  Cerebrovascular Reactivity Measurement Using Magnetic Resonance Imaging: A Systematic Review.

Authors:  Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton
Journal:  Front Physiol       Date:  2021-02-25       Impact factor: 4.566

5.  Leptomeningeal collateral activation indicates severely impaired cerebrovascular reserve capacity in patients with symptomatic unilateral carotid artery occlusion.

Authors:  Martina Sebök; Christiaan Hendrik Bas van Niftrik; Niklas Lohaus; Giuseppe Esposito; Mohamad El Amki; Sebastian Winklhofer; Susanne Wegener; Luca Regli; Jorn Fierstra
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-10       Impact factor: 6.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.